These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4140382)

  • 1. Letter: Lithium and M.R.I.H. in tardive dyskinesia.
    Ehrensing RH
    Lancet; 1974 Dec; 2(7894):1459-60. PubMed ID: 4140382
    [No Abstract]   [Full Text] [Related]  

  • 2. Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study.
    Ehrensing RH; Kastin AJ
    Arch Gen Psychiatry; 1974 Jan; 30(1):63-5. PubMed ID: 4587068
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Lithium and haloperidol in movement disorders.
    McCaul JA; Stern GM
    Lancet; 1974 May; 1(7865):1058. PubMed ID: 4133743
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of tardive dyskinesia with thiopropazate.
    Curran JP
    Am J Psychiatry; 1973 Aug; 130(8):925-7. PubMed ID: 4146097
    [No Abstract]   [Full Text] [Related]  

  • 5. Tardive dyskinesia: side effect or not?
    Curran JP
    Am J Psychiatry; 1973 Apr; 130(4):406-10. PubMed ID: 4144163
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Lithium in Parkinson's disease.
    McCaul JA; Stern GM
    Lancet; 1974 Jun; 1(7866):1117. PubMed ID: 4135282
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Treatment of tardive dyskinesia with lithium carbonate.
    Reda FA; Scanlan JM; Kemp K; Escobar JI
    N Engl J Med; 1974 Oct; 291(16):850. PubMed ID: 4420111
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Eur Neurol; 1974; 12(5-6):360-8. PubMed ID: 4614981
    [No Abstract]   [Full Text] [Related]  

  • 9. Lithium carbonate in the treatment of tardive dyskinesia.
    Reda FA; Escobar JI; Scanlan JM
    Am J Psychiatry; 1975 May; 132(5):560-2. PubMed ID: 804260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic releasing factors and Parkinson disease.
    Chase TN; Woods AC; Lipton MA; Morris CE
    Arch Neurol; 1974 Jul; 31(1):55-6. PubMed ID: 4209275
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation.
    Walter R; Griffiths EC; Hooper KC
    Brain Res; 1973 Oct; 60(2):449-57. PubMed ID: 4587290
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of tardive dyskinesia.
    Widroe HJ; Heisler S
    Dis Nerv Syst; 1976 Mar; 37(3):162-4. PubMed ID: 3393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of thyrotropin releasing hormone in animals and man: a generic hypothesis.
    Prange AJ; Wilson IC
    Psychopharmacol Bull; 1975 Jan; 11(1):22-4. PubMed ID: 804704
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.
    Gerlach J; Thorsen K; Munkvad I
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):51-6. PubMed ID: 788002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen influence on the hypothalamic enzymes involved in the formation of melanocyte-stimulating hormone release-inhibiting factor (MSH-R-IF).
    Celis ME; Taleisnik S
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):142-4. PubMed ID: 4591390
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
    Castensson S; Sievertsson H; Lindeke B; Sum CY
    FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370
    [No Abstract]   [Full Text] [Related]  

  • 17. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma.
    Nair RM; Redding TW; Kastin AJ; Schally AV
    Biochem Pharmacol; 1973 Aug; 22(15):1915-9. PubMed ID: 4578947
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium carbonate, haloperidol, and irreversible brain damage.
    Cohen WJ; Cohen NH
    JAMA; 1974 Dec; 230(9):1283-7. PubMed ID: 4479505
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Clomipramine infusion and lithium carbonate: a synergistic effect?
    O'Flanagan PM
    Lancet; 1973 Oct; 2(7835):974. PubMed ID: 4126603
    [No Abstract]   [Full Text] [Related]  

  • 20. Lithium carbonate for depression and mania.
    Wharton RN
    JAMA; 1970 Feb; 211(8):1379. PubMed ID: 5467042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.